NuChem Sciences Revenue and Competitors
Estimated Revenue & Valuation
- NuChem Sciences's estimated annual revenue is currently $46M per year.
- NuChem Sciences's estimated revenue per employee is $201,000
Employee Data
- NuChem Sciences has 229 Employees.
- NuChem Sciences grew their employee count by 16% last year.
NuChem Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Drug Discovery | Reveal Email/Phone |
2 | Senior Director, Human Resources and Operations | Reveal Email/Phone |
3 | Senior Director, Head Chemistry | Reveal Email/Phone |
4 | Executive Director Medicinal Chemistry | Reveal Email/Phone |
5 | Senior Director, Cell Biology | Reveal Email/Phone |
6 | Senior Director | Reveal Email/Phone |
7 | Director, DMPK | Reveal Email/Phone |
8 | Director | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Information Technology Manager | Reveal Email/Phone |
NuChem Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.2M | 11 | -27% | N/A | N/A |
#2 | $30.2M | 88 | -29% | N/A | N/A |
#3 | N/A | 15 | 50% | N/A | N/A |
#4 | $10.7M | 100 | 5% | $39.7M | N/A |
#5 | $104.3M | 228 | 45% | N/A | N/A |
#6 | $47.8M | 238 | N/A | N/A | N/A |
#7 | $15.5M | 77 | 5% | N/A | N/A |
#8 | $395.8M | 1969 | 7% | N/A | N/A |
#9 | $187.3M | 831 | 8% | N/A | N/A |
#10 | $361.6M | 1799 | 6% | N/A | N/A |
What Is NuChem Sciences?
NuChem Sciences a Drug Discovery and Chemical Development Contract Organization that Transform Ideas Through Science with an unparalleled knowledge base and a truly unique collaborative process, NuChem propels the dream of a potential breakthrough into a workable reality by launching the Discovery Partner Program(tm)
keywords:N/AN/A
Total Funding
229
Number of Employees
$46M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $68M | 229 | 27% | N/A |
#2 | $35M | 229 | 6% | N/A |
#3 | $66.5M | 229 | -5% | N/A |
#4 | $65.5M | 230 | 1% | N/A |
#5 | $35M | 231 | -10% | N/A |